<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101626570</journal-id>
<journal-id journal-id-type="pubmed-jr-id">42290</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Behav Neurosci Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Behav Neurosci Rep</journal-id>
<journal-title-group>
<journal-title>Current behavioral neuroscience reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2196-2979</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28191386</article-id>
<article-id pub-id-type="pmc">5295811</article-id>
<article-id pub-id-type="doi">10.1007/s40473-016-0100-7</article-id>
<article-id pub-id-type="manuscript">NIHMS823364</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Using Induced Pluripotent Stem Cells to Investigate Complex Genetic Psychiatric Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Temme</surname>
<given-names>Stephanie J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maher</surname>
<given-names>Brady J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Christian</surname>
<given-names>Kimberly M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA</aff>
<aff id="A2"><label>2</label>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA</aff>
<aff id="A3"><label>3</label>Lieber Institute for Brain Development, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA</aff>
<aff id="A4"><label>4</label>Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA</aff>
<aff id="A5"><label>5</label>Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA</aff>
<author-notes>
<corresp id="cor1">Correspondence: <email>kchris12@jhmi.edu</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P23">
<bold>Conflict of Interest</bold>
</p>
<p id="P24">Stephanie J. Temme, Brady J. Maher, and Dr. Kimberly M. Christian declare that they have no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>3</volume>
<issue>4</issue>
<fpage>275</fpage>
<lpage>284</lpage>
<!--elocation-id from pubmed: 10.1007/s40473-016-0100-7-->
<self-uri xlink:href="http://link.springer.com/article/10.1007/s40473-016-0100-7"></self-uri>
<abstract>
<sec id="S1">
<title>Purpose of Review</title>
<p id="P1">Induced pluripotent stem cells (iPSCs) can be generated from human patient tissue samples, differentiated into any somatic cell type, and studied under controlled culture conditions. We review how iPSCs are used to investigate genetic factors and biological mechanisms underlying psychiatric disorders, and considerations for synthesizing data across studies.</p>
</sec>
<sec id="S2">
<title>Recent Findings</title>
<p id="P2">Results from patient specific-iPSC studies often reveal cellular phenotypes consistent with postmortem and brain imaging studies. Unpredicted findings illustrate the power of iPSCs as a discovery tool, but may also be attributable to limitations in modeling dynamic neural networks or difficulty in identifying the most affected neural subtype or developmental stage.</p>
</sec>
<sec id="S3">
<title>Summary</title>
<p id="P3">Technological advances in differentiation protocols and organoid generation will enhance our ability to model the salient pathology underlying psychiatric disorders using iPSCs. The field will also benefit from context-driven interpretations of iPSC studies that recognize all potential sources of variability, including differences in patient symptomatology, genetic risk factors and affected cellular subtype.</p>
</sec>
</abstract>
<kwd-group>
<kwd>iPSCs</kwd>
<kwd>schizophrenia</kwd>
<kwd>bipolar disorder</kwd>
<kwd>autism spectrum disorders</kwd>
<kwd>psychiatric</kwd>
<kwd>cellular reprogramming</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>